Andorra Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.

Press releases published on May 28, 2026

May 28, 2026

Premium Craft Cannabis Brand Broken Coast Launches Cherry Ztripez Flower and Pre-Rolls for Summer

Indeterminate GlobeNewswire

May 28, 2026

TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer

Indeterminate GlobeNewswire

May 28, 2026

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 28, 2026

BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting

Indeterminate GlobeNewswire

May 28, 2026

BPGbio to Present Ongoing Phase 2 Study Trial-in-Progress Update of BPM31510 in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

May 28, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026

Indeterminate GlobeNewswire

May 28, 2026

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

May 28, 2026

Felix Offers Ozempic at Generic-Level Pricing as Lower-Cost GLP-1 Demand Remains Elevated Across Canada

Indeterminate GlobeNewswire

May 28, 2026

World Bicycle Day: Experience Denmark through Danish Wheelness™

Indeterminate GlobeNewswire

May 28, 2026

RadNet to Host Men's Health Webinar on June 13, 2026

Indeterminate GlobeNewswire

May 28, 2026

InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China

Indeterminate GlobeNewswire

May 28, 2026

XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters

Indeterminate GlobeNewswire

May 28, 2026

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

Indeterminate GlobeNewswire

May 28, 2026

Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

Indeterminate GlobeNewswire

May 28, 2026

ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

Indeterminate GlobeNewswire

May 28, 2026

Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026

Indeterminate GlobeNewswire

May 28, 2026

Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM

Indeterminate GlobeNewswire

May 28, 2026

Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma

Indeterminate GlobeNewswire

May 28, 2026

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

Indeterminate GlobeNewswire

May 28, 2026

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

Indeterminate GlobeNewswire